Defining a case of invasive aspergillosis by serum galactomannan

References

• Mennink-Kersten M A, Donnelly J P, Verweij P E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349–357
   PubMed Web of Science ®Google Scholar
• Stynen D, Sarfati J, Goris A, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60: 2237–2245
   PubMed Web of Science ®Google Scholar
• Stynen D, Goris A, Sarfati J, et al. A new sensitive sandwich ELISA to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497–500
   PubMed Web of Science ®Google Scholar
• Wheat L J. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003; 5: 158–166
   PubMedGoogle Scholar
• Ascioglu S, Rex J H, De Pauw B, et al. On behalf of the Invasive Fungal infections cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14
   PubMed Web of Science ®Google Scholar
• Verweij P E, Stynen D, Rijs A J, et al. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995; 33: 1912–1914
   PubMed Web of Science ®Google Scholar
• Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis 1996; 15: 232–237
   Google Scholar
• Sulahian A, Tabouret M, Ridbaud P, et al. Comparison of enzyme immunoassay and latex agglutination test detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996; 15: 139–145
   PubMed Web of Science ®Google Scholar
• Bretagne S, Marmorat-Khuong A, Kuentz M, et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA : practical use in neutropenic patients. J Infect 1997; 35: 7–15
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ridbaud P, et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric haematology units during a 4-year prospective study. Cancer 2001; 91: 311–318
   PubMed Web of Science ®Google Scholar
• Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223–3228
   PubMed Web of Science ®Google Scholar
• Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604–1610
   PubMed Web of Science ®Google Scholar
• Williamson E C M, Oliver D A, Johnson E M, et al. Aspergillus antigen testing in bone marrow transplant recipients. J Clin Pathol 2000; 53: 362–366
   PubMed Web of Science ®Google Scholar
• Ulusakarya A, Chachaty E, Vantelon J M, et al. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematol J 2000; 1: 111–116
   PubMedGoogle Scholar
• Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898–906
   PubMed Web of Science ®Google Scholar
• Pfeiffer C, Fine J, Safdar N. Performance of galactomannan assay for diagnosis of Aspergillus: a meta-analysis. 43rd Annual meeting of the Infectious Diseases Society of America 2005, San Francisco, CA, abstract # 284.
   Google Scholar
• Lijmer J, Mol B W, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic test. JAMA 1999; 282: 1061–1066
   PubMed Web of Science ®Google Scholar
• Lijmer J G, Bossuyt P M M, Heisterkamp S H. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Statist Med 2002; 21: 1525–1537
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander B D, Kett D H, et al. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–659
   PubMed Web of Science ®Google Scholar
• Upton A, Leisenring W, Marr KA. (1→3) beta -d-Glucan assay in the diagnosis of invasive fungal infections. Clin Infect Dis 2006; 42:1054–6.
   PubMed Web of Science ®Google Scholar
• De Repentigny L. Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis. Clin Infect Dis 1992; 14(Suppl1)S11–S22
   Google Scholar
• Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1,3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733–2741
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes A W S, Reitsma J B, et al. Sources of variation and bias in studies of diagnostic accuracy. A systematic review. Ann Intern Med 2004; 140: 189–202
   PubMed Web of Science ®Google Scholar
• Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306
   PubMed Web of Science ®Google Scholar
• Marr K A, Balajee S A, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641–649
   PubMed Web of Science ®Google Scholar
• Stephens-Romero S D, Mednick A J, Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005; 73: 114–125
   PubMed Web of Science ®Google Scholar
• Balloy V, Huerre M, Latgé J P, et al. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494–503
   PubMed Web of Science ®Google Scholar
• Berenguer J, Allende M C, Lee J W, et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporin and methyl-prednisolone-induced immunosuppression. Am J Resp Crit Care Med 1995; 152: 1079–1086
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Botterel F, Pautas C, , et al. Galactomannan antigenaemia has a higher diagnostic yield in invasive aspergillosis in deeply neutropenic patients than in others. Bone Marrow Transplant 2006; 37 (suppl 1): abstr # P674.
   Google Scholar
• Husain S, Kwak E J, Obman A, et al. Prospective assessment of Platelia™ Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004; 4: 796–802
   PubMed Web of Science ®Google Scholar
• Kwak E J, Husain S, Obman A, et al. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004; 42: 435–438
   PubMed Web of Science ®Google Scholar
• Cimolai N. Serodiagnosis for bacterial infections. In: Nevio Cimolai, ed., Laboratory Diagnosis of Bacterial Infections, 1st edn. New York and Basel: Marcel Dekker, 2001.
   Google Scholar
• Maertens J, Theunissen K, Verbeken E, et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 126: 852–860
   PubMed Web of Science ®Google Scholar
• Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based pre-emptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242–1250
   PubMed Web of Science ®Google Scholar
• Verweij P E, Erjavec Z, Sluiters W, et al. Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses. J Clin Microbiol 1998; 36: 1612–1616
   PubMed Web of Science ®Google Scholar